ACB
Aurora Cannabis·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Ample Liquidity
High Gross Profit Margin
Significant Net Income Growth
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ACB
Aurora Cannabis Inc.
A global leader in the cannabis industry that serving both the medical and consumer markets
2207 90B St. SW
Edmonton
Alberta
T6X 1V8
Canada
--
Aurora Cannabis Inc., was incorporated on December 21, 2006 under the Business Corporations Act (British Columbia). The company's main strategic business areas focus on the production, distribution and sale of cannabis and cannabis-related products in Canada and internationally.
Earnings Call
Q1/2026
Estimate EPS--
Actual EPS-0.198238
Estimate Revenue70.27M
Actual Revenue71.97M
Aurora Cannabis Q1 2026: Navigating Contradictions in Germany’s Market Expansion and Supply Chain Challenges
Aug 06,2025 12:19
Earnings Decrypt
Earnings Decrypt
Q4/2025
Estimate EPS--
Actual EPS--
Estimate Revenue64.93M
Actual Revenue--
Aurora Cannabis Q4 2025: Navigating Contradictions in Supply Chains, Margins, and Market Growth
Jun 18,2025 10:48
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ACB has released its 2025 Q1 earnings. EPS was reported at 0.08, versus the expected -0.35, beating expectations. The chart below visualizes how ACB has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ACB has released its 2026 Q2 earnings report, with revenue of 64.89M, reflecting a YoY change of 8.07%, and net profit of -38.09M, showing a YoY change of -289.73%. The Sankey diagram below clearly presents ACB's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
